Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma

Gut

Volumn 42, Issue 1, 1998, Pages 88-91

  Syrigos, K N ^b   Fyssas, I ^a   Konstandoulakis, M M ^a   Harrington, K J ^b   Papadopoulos, S ^a   Milingos, N ^a   Peveretos, P ^a   Golematis, B C ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Chorionic gonadotropin; Pancreatic cancer; Paraneoplastic syndrome; Tumour marker; Human chorionic gonadotropin

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; FLUOROURACIL; FOLINIC ACID; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE METASTASIS; CHOLEDOCHOJEJUNOSTOMY; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROJEJUNOSTOMY; HORMONE BLOOD LEVEL; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031971027     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.1.88     Document Type: Article

References (40)

1. National Cancer Institute. Annual Cancer Statistics Review 1990:1973-87.
2. Nix GA, Schmitz PJ, Wilson JHP. Carcinoma of the head of the pancreas. Therapeutic implications of endoscopic retrograde pancreatography. Gastroenterology 1984;87: 37-43.
3. Savarino V, Mansi C, Bistolfi L. Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage. Dig Dis Sci 1983;28:1078-82.
4. Cubilla AL, Fitzgerald PJ. Pancreas cancer (non-endocrine). A review. Part I. Clinical Bulletin of the Memorial Sloan-Kettering Cancer Center 1994;8:91-9.
5. Moosa AR, Levin B. The diagnosis of early pancreatic cancer: the University of Chicago experience. Cancer 1981; 47:1688-92.
6. Di Magno EP. Early diagnosis of chronic pancreatitis and pancreatic cancer. Med Clin North Am 1988,72:979-92.
7. Rosen SW, Weintraub BD, Aaronson SA. Non-random ectopic protein production by malignant cells: direct evidence in vitro. J Clin Endocrinol Metab 1980;50:834-41.
8. Braunstein GD, Vaitukaitis JL, Carbone PP, et al. Ectopic production of hCG by neoplasms. Ann Intern Med 1973;78:39-45.
9. Papapetrou PD, Sakarelou NP, Braouzi H, et al. Ectopic production of hCG in malignant tumors. Cancer 1978;42: 2583-92.
10. Birkenfeld S, Noiman G, Krispin M, et al. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors. Eur J Surg Oncol 1989;15:103-8.
11. Regelson W. Have we found the "definitive cancer biomarker"? Cancer 1995;76:1299-301.
12. Acedevo HF, Tong JY, Hartsock RJ. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 1995;76:1467-75.
13. Acedevo HF, Krichevsky A, Campbell-Acevedo EA, et al. Expression of membrane associated human chorionic gonadotropin, its subunits and fragments by cultured human cancer cells. Cancer 1992;69:1829-42.
14. Cancer of the Pancreas Task Force. Staging of cancer of the pancreas. Cancer 1981;47:163-9.
15. Hermanek P, Sobin LH. UICC, TNM classification of malignant tumours. Berlin: Springer Verlag, 1987:65-7.
16. Kloppel G, Maillet B. Classification and staging of pancreatic nonendocrine tumours. Radiol Clin North Am 1989;27: 105-12.
17. Bagshawe KD. Choriocarcinoma: a model for tumor markers. Acta Oncol 1992;31:99-106.
18. Gailani S, Ming Chu T, Nussbaum A, et al. hCG in nontrophoblastic neoplasms. Cancer 1976;38:1684-6.
19. Hattori M, Fukase M, Yoshim H, et al. Ectopic production of hCG by neoplasms. Cancer 1978;42:2328-33.
20. Buckely CH, Fox H. An immunohistochemical study of the significance of hCG secretion by large bowel adenocarcinoma. J Clin Pathol 1979;32:368-72.
21. Shousha S, Chappell R, Mattews J, et al. Human chorionic gonadotropin expression in colorectal adenocarcinoma. Dis Colon Rectum 1987;29:558-60.
22. Metz RA, Ritcher JJ, Leder LD. Adenocarcinoma of colon with syncytiotrophoblastic differentiation: differential diagnosis and implications. Pathol Res Pract 1985;179:419-24.
23. Tashjian AH, Weintraub BD, Barowski NJ, et al. Subunits of hCG; unbalanced synthesis and secretion by clonal cell strains derived from a bronchogenic carcinoma. Proc Natl Acad Sci USA 1975;70:1419-22.
24. Rosen SW, Weintraub BD, Vaitukaitis JL, et al. Placental proteins and their subunits as tumor markers. Ann Intern Med 1975;82:71-83.
25. Muggia FM, Rosen SW, Weintraub BD, et al. Ectopic placental proteins in nontrophoblastic tumors: serial measurements following chemotherapy. Cancer 1975;36:1327-37.
26. Greenway BA, Iqbal MJ, Johnson PI, et al. Low serum testosterone concentrations in patients with carcinoma of the pancreas. BMJ 1983;286:93-4.
27. Militello C, Sperti C, Foreita C, et al. Plasma levels of testosterone and hypophyseal gonadotropins in men affected by pancreatic cancer. Digestion 1984;30:106-11.
28. Adcock EW, Teasdale T, August CS, et al. Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression. Science 1973;181:845-7.
29. Starkey P.M. Natural killer cells large granular lymphocytes in pregnancy. Introduction. In: Lewis CE, McGee JO'D, eds. The natural killer cell. Now York: Oxford University Press, 1992:206-8.
30. Van Rinsum J, Smets LA, Van Rooy H, et al. Specific inhibition of human natural killer cell-mediated cytotoxicity by sialic acid and sialo-oligosaccharides. Int J Cancer 1986;38: 915-22.
31. Acedevo HF, Kellen JA, Wong ACH, et al. Expression of human choriogonadotropin-like material correlates with metastatic phenotype of R3230 AC rat adenocarcinoma. Cancer Invest 1987;5:177-85.
32. Hanna N, Filder I. Relationship between metastatic potential and resistance to natural killer cell-mediated cytotoxicity in three murine tumor systems. J Natl Cancer Inst 1981; 6:1183-90.
33. Moutzoauris G, Yannopoulos D, Barbatis C, et al. Is βhCG production by transitional cell carcinoma of the bladder a marker for aggressive disease and resistance to radiotherapy? Br J Urol 1993;72:807-9.
34. Carter PG, Iles RK, Neven P, et al. Measurement of urinary beta core fragment of human chorionic gonadotropin in women with vulvovaginal malignancy and its prognostic significance. Br J Cancer 1995;71:350-3.
35. Melmed S, Braunstein GD. Human chorionic gonadotropin stimulates proliferation of Nb2 rat lymphoma cells. J Clin Endocrinol Metab 1983;56:1068-70.
36. Wade TP, Radford DM, Virgo KS, et al. Complications and outcomes in the treatment of pancreatic adenocarcinoma in the United States Veteran. J Am Coll Surg 1994;179:38-47.
37. Watanapa P, Williamson RCN. Surgical palliation for pancreatic cancer: development during the past two decades. Br J Surg 1992;79:8-20.
38. Vaitukaitis JL, Rosen SW, Weintraub BD, et al. Gonadotropins and their subunits: basic and clinical studies. Recent Prog Horm Res 1976;32:289-331.
39. Gurchot C. The trophoblast theory of cancer. Oncology 1975,31:310-33.
40. Triozzi PL, Gochnour D, Martin EW, et al. Clinical and immunological effects of a synthetic β-human chorionic gonadotropin vaccine. Int J Oncol 1994;5:1447-53.